← Library


 

Effectively communicating about drugs and devices that benefit patients, companies and society is one of the biggest challenges biopharma companies face today. With health care moving toward more value-based care, health economic data considerations are increasingly influencing pharmaceutical companies and device manufacturers throughout the development process and may shape clinical trial design and endpoints.

 

In this playbook, we will examine common barriers to clear communication of health economic data in today’s healthcare environment, specifically within pharmaceuticals and medical devices.